Skip Nav Destination
Issues
1 August 2018
-
Cover Image
Cover Image
Oral squamous cell carcinoma (OSCC) is a highly debilitating and often fatal disease. Early detection is key, as early stage OSCC has a favorable prognosis and requires less aggressive treatment. Altered microRNA expression is a potential candidate for a molecular marker which can identify early malignant changes in the absence of clinically evident mucosal alterations. Yap et al (page 491) aimed to predict the presence of oral squamous cell carcinoma by selecting a panel of OSCC-related dysregulated microRNA identified jointly in data from formalin-fixed paraffin embedded (FFPE) and fresh frozen specimens for study in a novel sample type, oral swirls. Next generation sequencing (NGS) was used to determine microRNA fold changes in FFPE OSCC specimens relative to histologically normal epithelium (RDH-NGS). This data was placed with NGS of fresh frozen tissue data of The Cancer Genome Atlas database (TCGA). The cover shows a heatmap of expression values of TCGA-NGS data of the 29 microRNAs with fold changes greater (blue) or less (gray) than 1 (log2) in common with the RDH-NGS. Hierarchical clustering of samples was performed, with OSCC (n =292) displayed in black versus normal (n = 30) in red. Delineation of tumor and normal specimens utilizing these 29 candidate microRNAs yielded a sensitivity of 97.9% and specificity of 96.7%. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Review
Research Articles
In Vivo Multimodal Optical Imaging: Improved Detection of Oral Dysplasia in Low-Risk Oral Mucosal Lesions
Eric C. Yang; Richard A. Schwarz; Alexander K. Lang; Nancy Bass; Hawraa Badaoui; Imran S. Vohra; Katelin D. Cherry; Michelle D. Williams; Ann M. Gillenwater; Nadarajah Vigneswaran; Rebecca R. Richards-Kortum
Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer
Melinda S. Yates; Adriana M. Coletta; Qian Zhang; Rosemarie E. Schmandt; Meena Medepalli; Denise Nebgen; Beth Soletsky; Andrea Milbourne; Erma Levy; Bryan Fellman; Diana Urbauer; Ying Yuan; Russell R. Broaddus; Karen Basen-Engquist; Karen Lu
KLF4 Mediates the Effect of 5-ASA on the β-Catenin Pathway in Colon Cancer Cells
Sandra Parenti; Lucia Montorsi; Sebastian Fantini; Fabiana Mammoli; Claudia Gemelli; Claudio Giacinto Atene; Lorena Losi; Chiara Frassineti; Bruno Calabretta; Enrico Tagliafico; Sergio Ferrari; Tommaso Zanocco-Marani; Alexis Grande
DNA Methylation of Telomere-Related Genes and Cancer Risk
Brian T. Joyce; Yinan Zheng; Drew Nannini; Zhou Zhang; Lei Liu; Tao Gao; Masha Kocherginsky; Robert Murphy; Hushan Yang; Chad J. Achenbach; Lewis R. Roberts; Mirjam Hoxha; Jincheng Shen; Pantel Vokonas; Joel Schwartz; Andrea Baccarelli; Lifang Hou
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.